Diabetes drug before cancer may impact survival, study finds
NCT ID NCT07513259
First seen Apr 20, 2026 · Last updated May 12, 2026 · Updated 2 times
Summary
This study looked at over 200,000 adults with obesity and type 2 diabetes to see if the type of diabetes medication they took before a cancer diagnosis affected their survival and health after cancer. Researchers compared GLP-1 receptor agonists (like Ozempic) with other diabetes drugs. The goal was to find patterns in routine care, not to prove a treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chung Shan Medical University Hospital
Taichung, Taichung City, 402, Taiwan
Conditions
Explore the condition pages connected to this study.